Development System
CXCR4_site_10 | SCGE Toolkit
Database of study and experiment data generated by the Somatic Cell Genome Editing Consortium
A novel human T cell platform to define biological adverse effects of genome editing |
CXCR4_site_10 |
Calculated editing efficiency by targeted amplicon deep sequencing |
|
Editing Efficiency |
15000000479 |
|
SpCas9 |
P3 Nucleofection Kit |
Commercial Reagent |
CXCR4_site_10 |
|
|
Human |
CD4/CD8 Human Primary T cell |
|
nucleofection |
|
75 pmol Cas9 protein; 3-fold molar excess of sgRNA |
|
|
|
|
ribonucleoprotein (RNP) |
|
|
|
Measured Values |
Samples Size: | 3 |
|
Mean |
58.68  |
1 |
53.2908005762503  |
2 |
56.099015806740205  |
3 |
66.65235200845669  |
| |
|
Publication Title |
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI |